Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Items 801–900 of 1,000
Meneu, A., Lavoué, V., Guillermet, S., Lévêque, J., Mathelin, C., & Brousse, S. (2024) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2024.01.004 · Cited by 5
Chen, X., Zhang, H., Fang, Z., Wang, D., Song, Y., Zhang, Q., Hou, J., Yang, S., Xu, D., Fei, Y., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03433-y · Cited by 5
“instance, obesity was associated with the poorer overall survival and an increased risk of mortality, irrespective of menopausal status [5].”
BackgroundVarshney, S., Kumar, D., Choudhary, R., Gupta, A., Beg, M., Shankar, K., Rajan, S., Srivastava, A., Gupta, S., Khandelwal, N., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117330 · Cited by 5
Englisch, J. F., Englisch, A., Dannehl, D., Eissler, K., Tegeler, C. M., Matovina, S., Volmer, L. L., Wallwiener, D. R., Brucker, S. Y., Hartkopf, A. D., et al. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07786-7 · Cited by 5
“In early stage breast cancer, obesity is associated with advanced tumor stages and reduced overall and breast cancer-specific survival [11, 12].”
Jung, W., Park, S. H., Park, Y., Song, Y.-M., Park, J., Yu, J., Cho, I. Y., Kim, B. S., Han, K., & Shin, D. W. (2025) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07594-2 · Cited by 5
Holm, J. B., Skovbjerg, S., Nielsen, H. M., Christiansen, P., Bruun, J. M., Alsner, J., Cronin-Fenton, D. P., & Borgquist, S. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02083-w · Cited by 5
Recurrence Score gene group components and outcomes in the RxPONDER trial (SWOG S1007)
Abdou, Y. G., Hoag, J. R., Barlow, W. E., Albain, K. S., Gralow, J. R., Meric‐Bernstam, F., Hayes, D. F., Lin, N., Perez, E. A., Goldstein, L. J., et al. (2026) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djag221 · Cited by 5
Wang, J.-B., Lin, M., Xie, J., Lin, J., Lü, J., Chen, Q., Cao, L., Lin, M., Tu, R., Li, P., et al. (2020) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2020.03.023 · Cited by 5
Kehm, R. D., Llanos, A. A. M., McDonald, J. A., Tehranifar, P., & Terry, M. B. (2022) · Cancers · doi:10.3390/cancers14174122 · Cited by 5
“Emerging evidence supports a relationship between obesity and poorer response to neoadjuvant chemotherapy [64–66] and with poorer breast cancer outcomes irrespective of menopausal status [67,68].”
BackgroundSmith, A., Mullooly, M., Murphy, L., Barron, T. I., & Bennett, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202291 · Cited by 5
obesity paradox and mortality after pathological hip fractures: a Swedish registry study
Ehne, J., Tsagozis, P., Lind, A., Wedin, R., & Hedström, M. (2022) · Acta Orthopaedica · doi:10.2340/17453674.2021.1020 · Cited by 5
“It is possible that our study is underpowered regarding the female subgroup, yet another explanation could be that in breast cancer, the leading cause of cancerrelated death in females, a high BMI is associated with a negative effect on survival, and this might eradicate the postulated protective factor of having ext…”
BackgroundResultThe Effect of Diet Intervention in Breast Cancer: A Meta-analysis
Chung, B. Y., & Oh, E. H. (2017) · Asian Oncology Nursing · doi:10.5388/aon.2017.17.1.1 · Cited by 5
Rech, D. (2018) · Americanae (AECID Library) · Cited by 5
Vaysse, C., Lømo, J., Garred, Ø., Fjeldheim, F., Lofterød, T., Schlichting, E., McTiernan, A., Frydenberg, H., Husøy, A., Lundgren, S., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0030-x · Cited by 5
Self-citationNock, N. L., Jiang, H., Borato, L., Alberts, J., & Dimitropoulos, A. (2020) · Nutrition & Diabetes · doi:10.1038/s41387-020-0124-7 · Cited by 4
Mensah, D. K., DeGraft-Johnson, P. K. G., Darkwa, E. O., Akowuah, A., Danso, O.-S., Aryee, G., Essuman, R., & Djagbletey, R. (2024) · Cureus · doi:10.7759/cureus.63397 · Cited by 4
Lee, J., Bae, S. J., Kim, H. K., Nam, S. J., Kim, H. J., Bae, S. Y., Park, H. Y., Ko, B. K., Park, J. H., Kwon, Y., et al. (2025) · The Breast · doi:10.1016/j.breast.2025.104515 · Cited by 4
Prognostic significance of anthropometric measurements in gastric cancer: a multicenter cohort study
Xie, H., Wei, L., Wang, S., Shi, H., & Chen, J. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09849-0 · Cited by 4
Firmicutes in gut microbiota: hormonal influence on breast cancer in obese individuals
Chen, J., Zhang, Z., Ma, M., Huang, Q., Ling, Z., Liu, Y., Gao, Z., Wang, S., Zhu, Y., Zhang, L., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-03562-4 · Cited by 4
Survival outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer patients
Wang, C., Zhang, J., Chen, J., Zhang, X., Zhang, S., Zhang, P., & Li, J. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf356 · Cited by 4
Gheban, B., Mocan, L. P., Boşca, A. B., Suflețel, R. T., Dronca, E., Jianu, M. E., Crivii, C. B., Paşcalău, T. C., Onofrei, M. M., Crintea, A., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14020349 · Cited by 4
“A meta-analysis reported that obese or overweight breast cancer patients develop larger and higher-grade malignancy tumors, more frequent positive lymph nodes and distant metastasis, lower survival rate and worse overall prognostic [177].”
Biganzoli, G., Isnaldi, E., Richard, F., Marano, G., Boracchi, P., Maetens, M., Floris, G., Neven, P., Jérusalem, G., Munzone, E., et al. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.115438 · Cited by 4
Pérez‐Segura, P., Palacio, J., Vázquez, L., Monereo, S., Peñas, R. D. L., de Icaya, P. M., Grávalos, C., Lecube, A., Blasco, A., García‐Almeida, J. M., et al. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1601-2 · Cited by 4
“At the same time, overweight and obesity are linked to a higher risk of recurrence and breast cancer death [7], although there are to date no conclusive studies of prostate cancer patients [23].”
BackgroundKowalski, A., Striley, C. W., Varma, D. S., Egan, K. M., & Yaghjyan, L. (2018) · Journal of Breast Cancer · doi:10.4048/jbc.2018.21.2.158 · Cited by 4
Calvo, I., González-Rodríguez, M., Neria, F., Gallegos, I., García-Sánchez, L., Sánchez-Gómez, R., Pérez, S., Arenas, M. F., & García‐Estévez, L. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03469-6 · Cited by 4
“Our findings are in line with previous reports on the association between increased BMI and higher breast cancer incidence in postmenopausal, but not in pre-menopausal, women [4–7]: 68% of obese patients were postmenopausal and 61.9% of patients with normal weight were premenopausal.”
BackgroundResultInfluentialLi, Q., Wang, Y., Ren, L., & Liu, Z. (2024) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000058 · Cited by 4
Health behaviour changes in female cancer survivors: The Seintinelles study
Paunescu, A., Préau, M., Jacob, G., Pannard, M., Delrieu, L., Delpierre, C., & Kvaskoff, M. (2023) · Bulletin du Cancer · doi:10.1016/j.bulcan.2023.02.008 · Cited by 4
Perceptions of Primary Care Among Breast Cancer Survivors: The Effects of Weight Status
Christian, A. H., Hudson, S. V., Miller, S. M., Bator, A., Ohman‐Strickland, P., Somer, R. A., & Ferrante, J. M. (2015) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392815587487 · Cited by 4
“41% more likely to die of any cause.(10) Approximately 70% of women are overweight at the time of their breast cancer diagnosis, and additional weight gain often results from the standard treatment regimens.”
BackgroundWeight Management: Perception, Interest, and Preferences in Adult Cancer Survivors
Zhang, F. F., Meagher, S. M., Koch‐Weser, S., Singer, M., Dhaundiyal, G., Erban, J. K., & Saltzman, E. J. (2017) · Clinical journal of oncology nursing · doi:10.1188/17.cjon.65-71 · Cited by 4
“None were underweight (BMI less than 18.5 kg/m2), 35% (n = 69) were overweight (BMI = 25-29.9 kg/m2), and 27% (n = 54) were obese (BMI of 30 kg/m2 or greater).”
InfluentialEating Habits and Preferences of Polish Women Undergoing Treatment for Breast Cancer
Demuth, A., & Czerniak, U. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.6.1803 · Cited by 4
Demırel, P. B., Özorhan, Ü., Tuna, B. G., Cleary, M. P., & Doğan, S. (2019) · Annals of Medical Research · doi:10.5455/annalsmedres.2019.09.542 · Cited by 4
“Since both obesity and type 2 diabetes are related to insulin resistance, the association between obesity, diabetes and breast cancer is attributed mostly to the insulin resistance, which is involved in the worse prognosis of breast cancer in diabetic (4) and obese (6, 7) patients.”
BackgroundDepiesse, F., & Coste, O. (2016) · Elsevier eBooks · doi:10.1016/b978-2-294-74464-8.00013-9 · Cited by 4
Pallin, N. D., Beeken, R. J., Pritchard‐Jones, K., Charlesworth, L., Woznitza, N., & Fisher, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039909 · Cited by 4
Abusanad, A. M., Alghamdi, B., Alghamdi, R., Khallaf, R., Faisal, K., & Bishnaq, R. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_596_20 · Cited by 4
“[11] In recent meta-analysis, BC‐specific death among obese women is higher compared to normal weight women.[12] Another study among women aged 65–79 years old indicated that high BMI is associated with a higher risk of having IDC, although it was not statistically significant.”
BackgroundThe Effect of The Body Composition to Prognosis in Young Breast Cancer Patients
Beypınar, İ., Kaya, F., & Demir, H. (2021) · Akdeniz Medical Journal · doi:10.53394/akd.979541 · Cited by 4
Gregoric, G., Gaculenko, A., Nagel, L., Popp, V., Maschauer, S., Prante, O., Saake, M., Schett, G. A., Uder, M., Ellmann, S., et al. (2022) · Cancers · doi:10.3390/cancers14102482 · Cited by 4
Turkish Women Breast Self-Examination Knowledge and Practices: A Systematic Review
Aydın, A., Koçan, S., & Gürsoy, A. (2021) · DergiPark · Cited by 4
Genetic predisposition to obesity and inflammation in a tri-racial/ethnic breast cancer population
Puyana, C., Schindler, E., Lee, E. K., & Hu, J. J. (2022) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2021.51 · Cited by 4
Obesity, Cancer, and Health Equity
Nyrop, K. A., Gaddy, J. J., & Charlot, M. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2022.10.024 · Cited by 4
Bilić, I. (2014) · Periodicum Biologorum · Cited by 4
Þrek, holdafar og heilsutengd lífsgæði eftir krabbameinsmeðferð
Gudmundsson, G. H., Jóhannsson, E., & Jóhannsson, E. (2020) · Læknablaðið · doi:10.17992/lbl.2020.04.575 · Cited by 4
Dreher, M. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-59180-3_20 · Cited by 4
RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741
Kwan, M. L., Quesenberry, C. P., & Caan, B. J. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv333 · Cited by 4
Sarcopenia and monocyte-to-lymphocyte ratio as prognostic factors in early-stage breast cancer
Zattarin, E., & Vernieri, C. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.171 · Cited by 4
“Of note, high BMI has been associated with worse survival in BC patients, with some exceptions (5-7).”
Ho, K. L., Tu, Y., Dibble, K. E., Visvanathan, K., & Connor, A. E. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07543-z · Cited by 3
Dzidzornu, E., O'Fee, A., Hogan, S., McCarthy, N. S., Stewart, E., Madeley, C., Wilkes, J., White, A., Hickey, M., Wylie, E. J., et al. (2024) · Radiography · doi:10.1016/j.radi.2024.11.005 · Cited by 3
Yoon, K. H., Yoon, Y. E., Jeong, S., Kang, J., Oh, J. H., Koh, H. W., Shin, H.-C., & Kim, E. K. (2025) · Breast Cancer Research and Treatment · doi:10.1007/s10549-025-07823-2 · Cited by 3
Immune system, inflammatory response, and regulated cell death in breast cancer research (Review)
Li, G., Jin, B., Zhou, J., Fang, S., & Fan, Z. (2025) · Oncology Reports · doi:10.3892/or.2025.9016 · Cited by 3
Kwan, M. L., D’Addario, L. L., Lee, C., Roh, J. M., Ergas, I. J., Shariff‐Marco, S., Cheng, I. C., Behren, J. V., Wu, A. H., Morey, B. N., et al. (2026) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djag062 · Cited by 3
Hartkopf, A. D., Albert, U., Bartsch, R., Bauerfeind, I., Banys‐Paluchowski, M., Bjelic‐Radisic, V., Blohmer, J., Dall, P., Fallenberg, E. M., Fasching, P. A., et al. (2026) · The Breast · doi:10.1016/j.breast.2026.104873 · Cited by 3
“Age (AGO ++ ), menopausal status (AGO ++ ), body mass index (BMI, AGO + ), concomitant medications, physical and psychological comorbidities, performance status, as well as the patient's preferences are key factors in determining an optimal treatment strategy [1,2].”
Llanos, A. A. M., Aremu, J. B., Cheng, T. D., Chen, W., Chekmareva, M. A., Feliciano, E. M. C., Qin, B., Lin, Y., Omene, C. O., Khoury, T., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.879164 · Cited by 3
Self-citationRole of weight lost in breast cancer-related lymph
Molina, Y. R., Quitzke, S. A. A., Dotes, A. B. P., Reyes, L. M. T., & Valdivielso, P. (2022) · Rehabilitación · doi:10.1016/j.rh.2022.10.002 · Cited by 3
van Maldegem, S. J. M. V. C. –., Mols, F., Seidell, J. C., de Kruif, A. J. T. C. M., van de Poll-Franse, L. V., & Hoedjes, M. (2023) · Annals of Behavioral Medicine · doi:10.1093/abm/kaad049 · Cited by 3
“To decrease these risks and to increase health-related quality of life [10–15], recommendations regarding lifestyle and maintaining a healthy bodyweight have been issued [16].”
BackgroundThelwell, M., Masters, N., Appleyard, R., & Bullas, A. M. (2024) · Applied Sciences · doi:10.3390/app14020834 · Cited by 3
Iwase, T., Parikh, A. M., Wenli, D., Shen, Y., Adams, D. L., Tang, C., Cohen, E. N., Reuben, J. M., Shrimanker, T. V., Chainitikun, S., et al. (2024) · Journal of Cancer · doi:10.7150/jca.89453 · Cited by 3
Liu, Y., Jesus, E. D., Goldbach, M. M., Krouse, R. S., Guerra, C. E., Rendle, K. A. S., Cadet, T. J., Allison, K. C., & Tchou, J. C. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08999-x · Cited by 3
Gu, J., Zhang, H., Qian, K., Ye, X., & Wu, G. (2024) · International Journal of Women s Health · doi:10.2147/ijwh.s496718 · Cited by 3
Adams-Reyes, N., Coral‐Vázquez, R. M., Méndez, J. P., Tenorio, A., Zenteno, J. C., Villegas-Ruíz, V., & Canto, P. (2019) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.19002909 · Cited by 3
AL‐Janabi, A. A. H. S. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2125299 · Cited by 3
“Survival rates for breast cancer patients have also decreased in those who are obese or have high BMI (Chan et al. 2014).”
BackgroundReview on: relevance of breast cancer recurrence with body mass index or obesity
Jangir, N., & Kchhawa, D. S. (2022) · International Surgery Journal · doi:10.18203/2349-2902.isj20223185 · Cited by 3
Giraudo, C., Cavallin, C., Pillon, M., Carraro, E., Fichera, G., Cecchin, D., & Zucchetta, P. (2024) · European Radiology · doi:10.1007/s00330-024-10957-4 · Cited by 3
Lifestyle Behaviors and Needs After Breast Cancer Diagnosis: A Qualitative Assessment
Sauls, R., Buro, A. W., Brown, N. I., Riccardi, D., Mallory, M. A., Hoover, S. J., Laronga, C., Pabbathi, S. R., & Carson, T. L. (2024) · American Journal of Health Promotion · doi:10.1177/08901171241266562 · Cited by 3
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project
Gori, S., Rose, F. D., Ferro, A., Fabi, A., Angiolini, C., Azzarello, G., Cancian, M., Cinquini, M., Arecco, L., Aristei, C., et al. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102832 · Cited by 3
Pedagogical strategies for enhancing physical activity: A systematic review of trends and approaches
Jagiełło, M., & Lochbaum, M. R. (2024) · Pedagogy of Health · doi:10.15561/health.2024.0201 · Cited by 3
Mulugeta, C., Emagneneh, T., Kumie, G., Sisay, A., Abebaw, N., Ayele, M., & Alamrew, A. (2025) · Archives of Public Health · doi:10.1186/s13690-025-01514-6 · Cited by 3
“However, this finding contrasts with earlier research conducted in Italy [92], in Germany [93], in USA [94, 95], in UK [21, 96] in California [20] and Australia [97] which found that obese breast cancer patients were at higher risk for death and had reduced survival rates.”
Body mass index and cancer survival: a meta-analysis of cohort studies
Li, L., Tang, M., Zhong, S., Zhang, X., Wang, J., Meng, S., & Xu, R. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-03938-6 · Cited by 3
“Previous research also reported that underweight was an important predictor of poor outcomes in cancer patients [34, 35].”
Índice de masa corporal como pronóstico de supervivencia en pacientes operadas con cáncer de mama
García, J. L., Ramírez, L. M., Albuerne, N. B., Pérez, M. L., Concepción, I. R., & Calvo, V. F. (2019) · Acta Médica · Cited by 3
Солопова, А. Г., Vlasina, A. Y., Son, E. A., Ivanov, A. E., & Иванова, Е. А. (2020) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2020.146 · Cited by 3
Barengolts, E. I., Salim, M., Akbar, A., & Salim, F. (2020) · Nutrition and Dietary Supplements · doi:10.2147/nds.s243097 · Cited by 3
Ali, H., & Al-Tawri, E. (2020) · The Medical Journal of Basrah University · doi:10.33762/mjbu.2020.128412.1037 · Cited by 3
Suganya, M., Prabakar, S., & Rao, U. M. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00150 · Cited by 3
Saxton, J., & Wilson, C. (2022) · Proceedings of The Nutrition Society · doi:10.1017/s0029665122002889 · Cited by 3
Yoo, H. J., Kim, S. I., Kim, S. J., Won, I., & Cho, D. S. (2023) · Journal of Urologic Oncology · doi:10.22465/juo.224400480024 · Cited by 3
OBESITY AND CANCER: AN UNDERESTIMATED TOXIC RELATIONSHIP
Talib, W. H. (2023) · FARMACIA · doi:10.31925/farmacia.2023.3.1 · Cited by 3
“At the time of diagnosis, women who are obese and have breast cancer are more likely to die than patients who are of normal weight [85].”
Guo, L., Xie, Y., He, J., Li, X., Zhou, W., & Chen, Q. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05181-4 · Cited by 3
“Several meta-analyses found that obesity was associated with a 35–40% increased risk of recurrence and death, regardless of menopause or hormone receptor status (Chan et al. 2014; Niraula et al. 2012).”
BackgroundPrevention Is Better Than Treatment
Kechagioglou, P., & Fuller-Shavel, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-51216-2_1 · Cited by 3
The Role of GPR84 in Medium-chain Saturated Fatty Acid Taste Transduction
Liu, Y. (2016) · Digital Commons - USU (Utah State University) · doi:10.26076/accc-6de4 · Cited by 3
Łacko, A. (2016) · Nowotwory Journal of Oncology · doi:10.5603/njo.2016.0044 · Cited by 3
“W metaanalizach badań stwierdzono, że u chorych otyłych w porównaniu z kobietami z prawidłową masą ciała ryzyko nawrotu i zgonu jest większe o około 30% [2, 3].”
Obesity and breast cancer – what’s new?
Goodwin, P. J. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1253470 · Cited by 3
Encabo, P. G., Valadés, D., de Cos, A. I., García‐Honduvilla, N., & Pérez‐López, A. (2019) · Science & Sports · doi:10.1016/j.scispo.2018.09.012 · Cited by 3
Body Mass Index and Outcomes in Germ-Cell Tumors
McGregor, B. A., Miller, R. E., O’Donnell, E., Albiges, L. K., Sweeney, C. J., & Markt, S. C. (2019) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2019.04.012 · Cited by 3
Lohmann, A. E., Pimentel, I., & Goodwin, P. J. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy080 · Cited by 3
Dong, L., Wei, S., Huang, Z. K., Liu, F., Xie, Y., Wei, J., Mo, C., Qin, S., Zou, Q., & Yang, J. (2024) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03306-8 · Cited by 2
Pang, J., Li, L., Yin, N., Dai, M., Zheng, S., Chen, M., Xue, J., & Wu, J. (2024) · Cancer Medicine · doi:10.1002/cam4.7248 · Cited by 2
Specificities of mammary and periprostatic adipose tissues: A perspective from cancer research
Rebeaud, M., Lacombe, M., Fallone, F., Milhas, D., Roumiguié, M., Vaysse, C., Attané, C., & Muller, C. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.05.016 · Cited by 2
Breast Cancer Prevention Behaviors Among Women: A Cross-Sectional Study
Doğan, D. A., & Serpici, A. (2024) · Artuklu Health · doi:10.58252/artukluhealth.1522519 · Cited by 2
Pastorino, R., Marafon, D. P., Hoxhaj, I., Grossi, A., Giraldi, L., Rondinò, A., Cadoni, G., Polesel, J., Serraino, D., Vecchia, C. L., et al. (2024) · American Journal of Cancer Research · doi:10.62347/uuxk7608 · Cited by 2
Allison, K. C., McCuen‐Wurst, C., Raevsky, A., Holmes, N., Goldbach, M. M., Guerra, C. E., Rendle, K. A. S., Cadet, T. J., Krouse, R. S., & Tchou, J. C. (2024) · Obesity Science & Practice · doi:10.1002/osp4.70023 · Cited by 2
Evaluation of the blood lipid profile pattern in female breast cancer patients in Jordan.
Alsarhan, A. A., Alsarhan, A. A., Al‐Odat, I., Khwaldeh, A., & Shara, B. A. (2024) · Nutrición clínica y dietética hospitalaria/Nutrición clínica, dietética hospitalaria · doi:10.12873/444alsarhan · Cited by 2
Jalili, F., Hajizadeh, M., Mehrabani, S., Ghoreishy, S. M., & Hodder, S. (2025) · Breast Cancer · doi:10.1007/s12282-025-01764-w · Cited by 2
“[56].”
Birsin, Z., Bükün, H. O., Nazlı, İ., Alkan, O., Günaltılı, M., Çerme, E., Aliyev, V., Cebeci, S., Jeral, S., Abbasov, H., et al. (2025) · Medicina · doi:10.3390/medicina61091604 · Cited by 2
“In contrast, various meta-analyses have demonstrated that obesity is associated with poorer outcomes in patients with breast cancer [22,23].”
Genetic Predisposition to Excess Body Weight and Survival in Women Diagnosed With Breast Cancer
Bodelón, C., Landry, M., Lori, A., Hodge, J. M., Choudhury, P. P., Rees‐Punia, E., Wang, Y., McCullough, L. E., Patel, A. V., & Teras, L. R. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.53687 · Cited by 2
Wang, S., Zheng, D., Wang, Z., Hou, R., Zhang, Z., You, Z., Zhou, J., Huang, Y., Quan, M., Zhou, J., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08625-0 · Cited by 2
“Importantly, SWE may detect subtle lipid-Received mediated stromal alterations even before overt weight gain or metabolic symptoms occur — a critical advantage since obese TNBC patients face approximately 30% higher recurrence and mortality [21].”
Console, P. D., Catalano, S., & Győrffy, B. (2026) · GeroScience · doi:10.1007/s11357-026-02257-0 · Cited by 2
“The findings revealed that obesity is associated with poorer OS and BC specific survival, regardless of menopausal status [105].”
Li, W., Qu, J., Li, W., Cao, Y., Xu, R., & Xu, L. (2026) · Nanoscale · doi:10.1039/d5nr05009j · Cited by 2
pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer
Park, C. S., Choi, J., Seong, M.-K., Hong, S., Kim, J., Park, I., Seol, H., Noh, W. C., & Kim, H. (2019) · Endocrine Connections · doi:10.1530/ec-19-0101 · Cited by 2
Träsel, H. D. A. V., Falcetta, F. S., de Almeida, F. K., Falcetta, M. R. R., Ribeiro, R. A., & Rosa, D. D. (2021) · Breast Care · doi:10.1159/000514469 · Cited by 2
Jiang, X., Liang, Q., Xu, H., Gu, S., & Liu, L. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/2492488 · Cited by 2
“However, a recent meta-analysis study found that in women, obesity was associated with higher all-cause and cancer-related mortality in breast cancer [56].”
A review of the impact of energy balance on triple-negative breast cancer
Akingbesote, N. D., Owusu, D., Liu, R., Cartmel, B., Ferrucci, L. M., Zupa, M., Lustberg, M. B., Sanft, T. B., Blenman, K., Irwin, M. L., et al. (2023) · JNCI Monographs · doi:10.1093/jncimonographs/lgad011 · Cited by 2
The prognostic impact of body mass index in breast cancer according to tumor subtype
Kim, J., Kim, J., Jung, E., Kwag, S.-J., Park, J., Cho, J.-K., Kim, H.-G., Jeong, C., Ju, Y., & Lee, Y. (2023) · Korean Journal of Clinical Oncology · doi:10.14216/kjco.23010 · Cited by 2
“Moreover, several meta-analyses of published data showed that obesity was associated with worse overall survival in both pre-and postmenopausal patients with breast cancer [4,16].”
Background
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.